OncoStem Diagnostics Competitors and Similar CompaniesClear all
Mirati Therapeutics's competitors and similar companies include Delcath Systems.
 Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. |  Delcath Systems Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology. | |
Founding Date | Founding Date 2013 | Founding Date 1988 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Zug, CH | Locations New York, US HQ Galway, IE Queensbury, US |
Employees | Employees 666% decrease | Employees 437% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $12.4m (FY, 2022) | Revenue (est.) $85.2m (FY, 2025) |
Cost of goods | Cost of goods $600k (FY, 2022) | Cost of goods $11.8m (FY, 2025) |
Gross profit | Gross profit $11.8m (FY, 2022) | Gross profit $73.4m (FY, 2025) |
Net income | Net income ($740.9m) (FY, 2022) | Net income $2.7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Delcath Systems
HQ
New York, US
Employees
43↓ 7% decrease
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
View company